Trials / Recruiting
RecruitingNCT07406191
WB-EMS Effects on Cardiometabolic Risk Factors
Effects of Intensive Muscle Training on Cardiometabolic Risk Factors - a Randomised Controlled Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- University of Erlangen-Nürnberg Medical School · Academic / Other
- Sex
- Male
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
From the age of 50 onwards, there is a disproportionate decline in muscle strength, mass and function, which can be prevented or at least delayed by physical training. Unfortunately, many training programmes are very time-consuming and strenuous and are therefore not carried out consistently. Whole-body electromyostimulation (WB-EMS), a technology in which all major muscle groups are stimulated with an adjusted stimulation level, could be a time-effective and joint-friendly alternative. However, there are some contraindications to the widespread use of this technology, which are particularly common in middle-aged and elderly people. For example, high blood pressure, which affects more than half of men over the age of 50 in Germany, is considered a contraindication for WB-EMS training. However, this assessment is not very reliable; at least, acute WB-EMS application does not lead to an increase in blood pressure. In addition, there are no study results available for long-term WB-EMS application in people with high blood pressure. The present study particularly investigate whether and to what extent several weeks of WB-EMS training has an effect on resting blood pressure in people with mild blood pressure. Additionally, the effect of WB-EMS on other cardiometabolic risk factors and physical function will be addressed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | WB-EMS | 12 weeks of WB-EMS, 1.5x20 min/week |
| OTHER | Control | 12 weeks without additional intervention and without life style changes |
Timeline
- Start date
- 2026-02-15
- Primary completion
- 2027-11-30
- Completion
- 2027-12-31
- First posted
- 2026-02-12
- Last updated
- 2026-04-14
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT07406191. Inclusion in this directory is not an endorsement.